Search Results 261-270 of 15385 for Orange Peel tea

  1. https://www.mayoclinic.org/symptoms_all.xml

  2. A Study To Evaluate The Safety And Effectiveness Of IFX-1 In Add-on To Standard Of Care In Granulomatosis With Polyangiitis (GPA) And Microscopic Polyangiitis (MPA) - Mayo Clinic

    Individuals with squamous cell or basal cell carcinomas of the skin and individuals with cervical carcinoma in situ who have received curative surgical ...

  3. A Study To Define Axl Expression Level In Skin Biopsy Specimens From Patients With Skin Cancer In Relation To Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to define the presence and role of Axl in the risk of skin cancers in patients with CLL as well as non-CLL patients. Participation ...

  4. Melanoma Relatlimab Nivolumab - Clinical Trials

    Participation eligibility · with type 1 diabetes mellitus; · hypothyroidism only requiring hormone replacement; · skin disorders (such as vitiligo, psoriasis, or ...

  5. A Study Of Pembrolizumab Alone As Therapy For Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    ... skin that has undergone potentially curative therapy, or in situ cervical cancer. Radiographically-detectable central nervous system (CNS) metastases and/or ...

  6. Evaluation Of The AMICUS Extracorporeal Photopheresis (ECP) System In Patients With Chronic Graft Versus Host Disease - Mayo Clinic

    Certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange. Participating Mayo Clinic locations. Study statuses ...

  7. Axatilimab Plus Standard Of Care Therapy For The Prevention Of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Cancer, ABRAXAS Trial - Mayo Clinic

    Sometimes the transplanted cells from a donor can attack the body's normal cells, causing GVHD. Symptoms of GVHD can include yellowing of the skin, mucous ...

  8. Phase II Randomized Trial Of MFOLFIRINOX +/- Ramucirumab In Advanced Pancreatic Cancer - Mayo Clinic

    mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both arms will continue treatment until ...

  9. Evaluate Sleep Quality from Wearable Physiologic Monitor - Mayo Clinic

    Habitual use of 3 or more cups of coffee/caffeinated tea per day. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

  10. A Study To Evaluate The Combination Of Binimetinib And Palbociclib In Treating Patients With KRAS And NRAS Mutant Metastatic Or Unresectable Colorectal Cancer - Mayo Clinic

    The purose of this study is to determine how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive ...